高血压脑出血患者治疗中依达拉奉对脑血管血液动力学参数及神经功能影响分析.docVIP

高血压脑出血患者治疗中依达拉奉对脑血管血液动力学参数及神经功能影响分析.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
高血压脑出血患者治疗中依达拉奉对脑血管血液动力学参数及神经功能影响分析

高血压脑出血患者治疗中依达拉奉对脑血管血液动力学参数及神经功能影响分析   【摘要】 目的:分析高血?耗猿鲅?患者治疗中依达拉奉对脑血管血液动力学参数及神经功能的影响。方法:选取2012年1月-2016年4月203例高血压脑出血患者,将患者分为对照组(n=94)和研究组(n=109)。对照组患者采用常规治疗方法,研究组患者采用依达拉奉治疗,对比两组患者脑血管动力参数脑血管平均流速(Vmean)、脑血管平均流量(Qmean)、血管外周阻力(R)、动态阻力(DR)及临界压(CP),神经功能量表mRS、SSS评分和临床疗效。结果:两组患者治疗前脑血管动力参数Vmean、Qmean、R、DR及CP等比较,差异均无统计学意义(P0.05)。治疗后研究组患者CP、DR和R均低于对照组,Qmean和Vmean均高于对照组,比较差异均有统计学意义(P0.05),两组患者治疗后mRS、SSS评分与各自治疗前对比差异均有统计学意义(P0.05)。研究组患者mRS评分明显低于对照组,SSS评分明显高于对照组,比较差异均有统计学意义(P0.05)。结论:高血压脑出血患者采用依达拉奉治疗可改善患者脑血管功能,改善脑血管动力学参数,神经功能得到提高,提高临床疗效。   【关键词】 脑出血; 依达拉奉; 血流动力学; 神经功能   【Abstract】 Objective:To analyze the effect of Edaravone on hemodynamic parameters and neurological function in patients with hypertensive intracerebral hemorrhage.Method:A total of 203 patients with hypertensive intracerebral hemorrhage were selected from January 2012 to April 2016 in this study.They were divided into the control group (n=94) and study group (n=109).The control group was treated with regular treatment.The study group was treated with Edaravone.The cerebrovascular parameters Vmean,Qmean,R,DR and CP,neurological function scale mRS,SSS score and clinical curative effects of two groups were compared.Result:There were no significant differences in Veman,Qmean,R,DR and CP between the two groups before treatment(P0.05).After treatment,the hemodynamics parameters of CP,DR and R were lower than those in the control group,Qmean and Vmean were higher than those in the control group,the differences were statistical significance(P0.05). The mRS and SSS scores of the two groups were statistically different from those before treatment(P0.05).The mRS score of the study group was significantly lower than that of the control group,and the SSS score was significantly higher than that of the control group,the differences were statistically significant(P0.05).Conclusion:The treatment of Edaravone in patients with hypertensive intracerebral hemorrhage can improve the cerebrovascular function,improve the cerebrovascula

文档评论(0)

189****7685 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档